NCT07143786View on ClinicalTrials.gov

Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2027

Conditions
Ischemic Stroke, Acute
Interventions
DRUG

iNSC-EV01

Intravenous induced neural stem cell-derived exosome

DRUG

Placebo

iNSC-EV01 mimics

All Listed Sponsors
collaborator

Wiseheart Co.Ltd

UNKNOWN

lead

Xuanwu Hospital, Beijing

OTHER

NCT07143786 - Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter